title: PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample.
abstract: OBJECTIVE
  To summarize baseline characteristics, health conditions, resource utilization and resource cost for the US population for the 90-day period preceding enrolment, stratified by body mass index (BMI) and the presence of abdominal obesity (AO).
  
  
  METHODS
  PROCEED (Prospective Obesity Cohort of Economic Evaluation and Determinants) is a multinational, prospective cohort of control (BMI 20-24.0 kg/m(2)), overweight (BMI 25-29.9 kg/m(2)) and obese (BMI >or= 30 kg/m(2)) subjects with AO and without AO [non-abdominal obesity (NAO)], defined by waist circumference (WC) >102 and 88 cm for males and females, respectively. Subjects were recruited from an Internet consumer panel. Outcomes were self-reported online. Self-reported anthropometric data were validated. Prevalence of conditions and utilization is presented by BMI class and AO within BMI class. Differences in prevalence and means were evaluated.
  
  
  RESULTS
  A total of 1067 overweight [n = 474 (NAO: n = 254 and AO: n = 220)] and obese [n = 493 (NAO: n = 39 and AO: n = 454)] subjects and 100 controls were recruited. Self-reported weight (r = 0.92) and WC (r = 0.87) were correlated with measured assessments. Prevalence of symptoms was significantly higher in groups with higher BMI, as were hypertension (p < 0.0001), diabetes (p < 0.0001) and sleep apnoea (p < 0.0001). Metabolic risk factors increased with the BMI class. Among the overweight class, subjects with AO had significantly more reported respiratory, heart, nervous, skin and reproductive system symptoms. Overweight subjects with AO reported a significantly higher prevalence of diabetes (13%) compared with overweight subjects with NAO (7%, p = 0.04). Mean healthcare cost was significantly higher in the higher BMI classes [control ($456 +/- 937) vs. overweight ($1084 +/- 3531) and obese ($1186 +/- 2808) (p < 0.0001)].
  
  
  CONCLUSIONS
  An increasing gradient of symptoms, medical conditions, metabolic risk factors and healthcare utilization among those with a greater degree of obesity was observed. The independent effect of AO on health and healthcare utilization deserves further study with a larger sample size.
authors: University of Virginia School of Medicine, Virginia, USA. amw6n@virginia.edu
authors: A M
authors: AM
authors: Wolf
authors: N
authors: N
authors: Finer
authors: A A
authors: AA
authors: Allshouse
authors: K B
authors: KB
authors: Pendergast
authors: B H
authors: BH
authors: Sherrill
authors: I
authors: I
authors: Caterson
authors: J O
authors: JO
authors: Hill
authors: L J
authors: LJ
authors: Aronne
authors: H
authors: H
authors: Hauner
authors: C
authors: C
authors: Radigue
authors: C
authors: C
authors: Amand
authors: J-P
authors: JP
authors: Despres
mesh_terms: D000328:Adult; D000368:Aged; D015992:Body Mass Index; D016022:Case-Control Studies; D019411:Clinical Laboratory Techniques / Q000191:economics / Q000706:statistics & numerical data*; D015331:Cohort Studies; D048909:Diabetes Complications / Q000453:epidemiology; D004632:Emergency Medical Services / Q000191:economics / Q000706:statistics & numerical data*; D005260:Female; D006306:Health Surveys; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D020407:Internet; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000191:economics*; D055553:Prescription Drugs / Q000191:economics* / Q000627:therapeutic use; D011446:Prospective Studies; D014481:United States; D055105:Waist Circumference
chemical_list: D055553:Prescription Drugs